Antifungal Stewardship

Prescribing information is available at the bottom of this page.

Despite being less common than bacterial infections, invasive fungal infections (IFIs) represent an important clinical threat, with a significant health and financial burden.2

This page is designed to support healthcare professionals in adopting antifungal stewardship in your practice. It includes both downloadable resources, as well as videos from UK healthcare professionals on their experiences. 

Please register or sign in below to view the content.

References

1. CRESEMBA® Summary of Product Characteristics.

2. NHS England. Antifungal Stewardship Implementation Pack 2019. Available https://www.england.nhs.uk/wp-content/uploads/2019/03/PSS1-meds-optimisation-trigger-5-antifungal-stewardship-implementation-pack-v7.pdf. Accessed January 2020.

Prescribing Information

This includes legal category, basic NHS cost and a link to SPC. Please click each relevant SPC link to be directed to EMC website.

CRESEMBA® (isavuconazole)
Cresemba® 100mg hard capsules – SPC
Legal Category: POM. Basic NHS Cost:14 caps pack £599.28
Cresemba® 200mg powder for concentrate for solution for infusion – SPC

Legal Category: POM Basic NHS Cost: 1 vial pack £297.84

PP-CRB-GBR-0713.  October 2020